Slowdown in the OTC products market in Poland in 2010
11% growth of the OTC market in 2009
In 2009, the Polish market of OTC medicines, dermocosmetics and dietary supplements was worth PLN 8.5bn (EUR 2.0bn), representing an 11% growth rate year on year. Thus, in spite of the economic crisis, the market expanded dynamically. "In 2009 the high flu incidence contributed to large market growth, especially in case of OTC medicines. In all, the number of flu cases in 2009 reached almost 1.1 million, the highest figure since 2003, when there were approximately 1.2 million reported" says Monika Stefanczyk, PMR Head Pharmaceutical Market Analyst and the report co-author. Other driving forces behind the market growth included price increases and launches of new products.
In 2010, the value of the market of OTC products will top PLN 8.7bn (EUR 2.2bn), according to PMR estimates. The growth rate of the market will slow to 3%, due to a high reference base and a lower number of infections compared with 2009. We predict that the OTC market will rise at a double-digit rate in the next two years, to exceed PLN 10.6bn (EUR 2.7bn) in 2012. Dietary supplements will be the primary driver of the market growth in the coming years. Although the growth rate for the dietary supplements market will be lower than in the preceding years, it should be noted that it will still be exceptionally high -for instance, it will be higher than the growth pace of the OTC medicines market. We assume that the trends which prevailed in the previous year, and positively stimulated sales, will continue. These trends include the aging population, growing interest in self-treatment, healthy lifestyle and healthy appearance, natural and herbal products.
Non-pharmacy channel contributes 13% of the market's worth
Taking into account only the market of OTC medicines and dietary supplements, according to PMR a mere 13% of the market's value was generated by the non-pharmacy distribution channel in 2009. "It is due to the fact that a list of products approved for trading in non-pharmacy outlets from October 2009 comprised 525 items (176 OTC medical products). According to a new list, which came into force in November 2010, only OTC medicines based on 52 active substances can be sold at non-pharmacy outlets (grocery stores, service stations, kiosks, chemist stores, etc.)" says Agnieszka Stawarska, PMR Pharmaceutical Market Analyst and the report co-author.
In the past, the list of OTC medicines admitted to trading at non-pharmacy outlets was defined by both the applicable classification criteria and the lists of medicinal products admitted to non-pharmacy trading. This situation raised numerous doubts as, in fact, if a product meeting the criteria set forth in the regulation on the classification criteria for medicinal products has appeared on the market, the list of products admitted to non-pharmacy trading should have been immediately updated and amended to include this product. Dietary supplements can be sold outside of pharmacies without any restrictions.
This press release is based on information contained in the latest PMR report entitled "OTC market in Poland 2010. Switch strategies and development forecasts for 2010-2012".
PMR (www.pmrcorporate.com) is a British-American company providing market information, advice and services to international businesses interested in Central and Eastern European countries as well as other emerging markets. PMR's key areas of operation include business publications (through PMR Publications), consultancy (through PMR Consulting) and market research (through PMR Research). Being present on the market since 1995, employing highly skilled staff, offering high international standards in projects and publications, providing one of most frequently visited and top-ranked websites, PMR is one of the largest companies of its type in the region.
ul. Dekerta 24, 30-703 Krakow, Poland
tel. /48/ 12 618 90 00, fax /48/ 12 618 90 08
Contact Person: Anna Rojek, firstname.lastname@example.org
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Slowdown in the OTC products market in Poland in 2010 here
News-ID: 156235 • Views: 961
More Releases from PMR Ltd.
Roads to be a driving force of the Bulgarian construction market
Access to EU funding and the investments in the energy sector are the predominant factors determining the development of the Bulgarian civil engineering construction sector in the next three years. It is expected that this segment will lead the development of the construction market in Bulgaria. According to the research company PMR’s latest report, entitled “Construction sector in Bulgaria 2012 – Development forecasts for 2012-2014”, the absorption rate of the programmes
Polish road construction market to grow nearly 25% in 2011
Activity in Polish road construction will peak in 2011 and 2012. Driven by substantial capital expenditure by the General Directorate for National Roads and Motorways (GDDKiA), the value of roadwork will exceed PLN 30bn (€7.5bn) already in 2011. Delays in the implementation of projects related to Euro 2012 and sustained investments in local roads will prepare the road market for the anticipated period of reduced spending on the construction of
Construction industry in Romania expected to stabilise in 2011
Prior to the start of the crisis, the Romanian construction industry was one of the most vibrant in the European Union. This changed dramatically in 2009, when construction output fell by 15%, with a similar reduction following in 2010. The current year should finally lead to a measure of stabilisation on the market, but growth is not likely to return before 2012. Romania was the region's best performer in construction a
Pharmaceutical contract manufacturing and API sourcing: why not Central Europe?
At present, only a few companies based in Central Europe and the Balkans emphasise their contract manufacturing and API sourcing services. There is relatively strong competition from companies from the Far East and from Western Europe. On the other hand, the potential of the region seems to be considerable, with Poland and the Czech Republic still the most attractive locations, according to the latest report from PMR, a research and
More Releases for OTC
Investigation for Long-Term Investors in shares of Volkswagen AG (OTC: VWAGY / O …
An investigation on behalf of current long-term investors in shares of Volkswagen AG (OTC: VWAGY / OTC: VLKAF / OTC: VWAPY) was announced over potential breaches of fiduciary duties by certain officers and directors at Volkswagen AG. Investors who purchased shares of Volkswagen AG (OTC: VWAGY / OTC: VLKAF / OTC: VWAPY) and currently hold any of those Volkswagen AG shares have certain options and should contact the Shareholders Foundation at
OTC: VWAGY / OTC: VLKAF / OTC: VWAPY Shareholder Notice: Update in Lawsuit again …
The Shareholders Foundation, Inc. announces that a lawsuit is pending for certain investors in Volkswagen AG (OTC: VWAGY) (OTC: VWAPY) shares. Investors, who purchased shares of Volkswagen AG (OTC: VWAGY) (OTC: VLKAF) (OTC: VWAPY), have certain options and should contact the Shareholders Foundation at email@example.com or call +1(858) 779 - 1554. On September 25, 2015, a lawsuit was filed against Volkswagen AG (alleged securities laws violations. The plaintiff claimed that the defendants
Foods Matrix Inc. Exploring OTC Markets Listing
Foods Matrix Inc. (FMI), a US based food processing startup is exploring options to list on the OTC Markets. FMI is in talks to acquire a distressed food processing unit in the state of Punjab, India for US $3 million. The deal may be sealed by the end of November, 2018, post completion of the ongoing due diligence. FMI may initially quote on the pink sheet segment of the OTC Markets
OTC Analgesics Market Report 2017-22: Pharmacy to Remain the Most Lucrative OTC …
A fresh study, covering “OTC Analgesics Market Forecast, Trend Analysis & Competition Tracking – Global Review 2017 to 2022” has been broadcasted to wide online repository of Fact MR, which presents deep focus on the healthcare market. This smart study contains precise data that offers a clear insight about market current scenario and future projections for the benefit of readers. Moreover, the study enclosed significant data which tends to make
7 Key Projections for OTC Analgesics Market
The global OTC analgesics market is projected to register an above-average CAGR during 2017 to 2022. Global sales of OTC analgesics is estimated to account for nearly US$ 25,000 Mn revenues by 2022-end. Request For Sample Report: https://www.factmr.com/connectus/sample?flag=S&rep_id=75 The trend of using off-label drugs that are affordable and unapproved, but effective in treating diseases, has been witnessing an upsurge over the past few years. Various off-label drugs including tricyclic antidepressants, antihistamines,
OTC Drug Market Report Research : 2017
Reports And Markets Publish a New Market Research Report On –" OTC Drug Market Report Research : 2017" Access Full Report With Table Of Contents @ https://www.reportsandmarkets.com/reports/asia-pacific-otc-drug-market-report-2017-1541262 In this report, the Asia-Pacific OTC Drug market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split Asia-Pacific into several